Search results for "GMO"

showing 10 items of 156 documents

Early life infection and host senescence

2018

IF 3.224 (2017); International audience; Advanced age is often associated with a chronic inflammatory status and inflammatory diseases. It has been suggested that exposure to infectious agents that stimulate the inflammatory response at early ages might have carry over effects in terms of accelerated senescence and increased mortality at late ages. However, not all pathogens and parasites have pro-inflammatory effects. In particular, parasitic nematodes have been shown to dampen the inflammatory response and to prevent or alleviate the symptoms of inflammatory diseases. We, therefore, tentatively predicted that early infection with a parasite that has anti-inflammatory properties might post…

0301 basic medicineSenescenceMaleAgingLPSRodent[SDV.MHEP.PHY] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]LongevityInflammationHeligmosomoides polygyrusBiochemistryHost-Parasite Interactions03 medical and health sciencesMice0302 clinical medicineEndocrinologyBiomarkers of aging[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesbiology.animalGeneticsmedicine[SDV.MHEP.PHY]Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]AnimalsMolecular BiologyStrongylida InfectionsNematodeInflammationNematospiroides dubiusbiology[SDV.MHEP.GEG] Life Sciences [q-bio]/Human health and pathology/Geriatry and gerontologyHost (biology)[SDV.MHEP.GEG]Life Sciences [q-bio]/Human health and pathology/Geriatry and gerontologyCell Biologybiology.organism_classificationPhenotype3. Good healthDisease Models Animal030104 developmental biologyNematodeImmunology[SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseasesMice Inbred CBAFemaleHeligmosomoides polygyrusmedicine.symptomBiomarkers[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology030215 immunology
researchProduct

Assessment of genetically modified maize 1507 × NK603 for renewal of authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐008)

2018

International audience; Following the submission of application EFSA-GMO-RX-008 under Regulation (EC) No 1829/2003 from Pioneer Hi-Bred International, Inc. and Dow AgroSciences LLC, the Panel on Genetically Modified Organisms of the European Food Safety Authority was asked to deliver a scientific risk assessment on the data submitted in the context of the renewal of authorisation application for the insect-resistant, herbicide-tolerant genetically modified maize 1507 x NK603, for food and feed uses, import and processing, excluding cultivation within the EU. The data received in the context of this renewal application contained a systematic search and evaluation of literature, updated bioin…

0301 basic medicineVeterinary (miscellaneous)[SDV]Life Sciences [q-bio]Plant Science010501 environmental sciences01 natural sciencesMicrobiology[SHS]Humanities and Social Sciences03 medical and health sciences1507 × NK603[SDV.IDA]Life Sciences [q-bio]/Food engineering[SDV.BV]Life Sciences [q-bio]/Vegetal Biology[SPI.GPROC]Engineering Sciences [physics]/Chemical and Process Engineering0105 earth and related environmental sciences2. Zero hungerrenewalGmoRegulation (EC) No 1829/2003Maize030104 developmental biologyScientific Opinion[SDE]Environmental Sciences1507 x NK603ParasitologyAnimal Science and ZoologyArticles 11 and 23Food ScienceRegulation (EC) No 1829/2003
researchProduct

Assessment of genetically modified maize NK603 x MON810 for renewal of authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐007)

2018

Efsa Panel On Genetically Modified Organisms (gmo)Scientific opinionRequestor:European Commission (DG SANTE)Question number:EFSA-Q-2017-00028; Following the submission of application EFSA-GMO-RX-007 under Regulation (EC) No 1829/2003 from Monsanto, the Panel on Genetically Modified Organisms of the European Food Safety Authority (GMO Panel) was asked to deliver a scientific risk assessment on the data submitted in the context of the renewal of authorisation application of the herbicide-tolerant and insect-resistant genetically modified maize NK603 x MON810. The data received in the context of this renewal application contained post-market environmental monitoring reports, a systematic searc…

0301 basic medicinemaïsVeterinary (miscellaneous)gmo[SDV]Life Sciences [q-bio]2405 ParasitologyogmTP1-1185Plant SciencemaizeMicrobiologyzea mays03 medical and health sciences0404 agricultural biotechnology1110 Plant Sciencearticles 11 and 23TX341-6411106 Food ScienceNK603xMON8102. Zero hungerrenewal030109 nutrition & dieteticsNutrition. Foods and food supplymaize; NK603xMON810; renewal; articles 11 and 23; Regulation (EC) No1829/2003indian cornChemical technology2404 MicrobiologyRegulation (EC) No 1829/2003maize;NK603 x MON810;renewal;articles 11 and 23;Regulation (EC) No 1829/2003NK603 x MON81010079 Institute of Veterinary Pharmacology and Toxicology04 agricultural and veterinary sciences040401 food scienceSettore AGR/02 - Agronomia E Coltivazioni Erbacee3401 Veterinary (miscellaneous)Scientific OpinionSettore AGR/11 - Entomologia Generale E ApplicataRegulation (EC) No1829/2003570 Life sciences; biologyAnimal Science and ZoologyParasitology1103 Animal Science and ZoologyNK603 x MON810Regulation (EC) No 1829/2003Food Science
researchProduct

Statement complementing the EFSA Scientific Opinion on application (EFSA‐GMO‐DE‐2011‐95) for the placing on the market of genetically modified maize …

2018

Abstract The GMO Panel was previously not in the position to complete the food/feed safety assessment of maize 5307 due to an inadequate 28‐day toxicity study necessary for an appropriate assessment of eCry3.1Ab protein. Following a mandate from the European Commission, the GMO Panel assessed a supplementary 28‐day toxicity study in mice on the eCry3.1Ab protein (1,000 mg/kg body weight (bw) per day) to complement its scientific opinion on application EFSA‐GMO‐DE‐2011‐95 for the placing on the market of the maize 5307 for food and feed uses, import and processing. The supplementary 28‐day toxicity study did not show adverse effects. Taking into account the previous assessment and the new in…

040301 veterinary sciencesVeterinary (miscellaneous)[SDV]Life Sciences [q-bio]2405 Parasitology28‐day studyPlant ScienceTP1-1185010501 environmental sciencesBody weight01 natural sciencesMicrobiology0403 veterinary scienceimport and processing1110 Plant ScienceEuropean commissionTX341-6411106 Food Science0105 earth and related environmental sciences2. Zero hungerGenetically modified maizebusiness.industryNutrition. Foods and food supplyGMOChemical technology2404 Microbiologyfungi10079 Institute of Veterinary Pharmacology and Toxicology04 agricultural and veterinary sciencesfood and feed safetyeCry3.1AbBiotechnologyCrop protection3401 Veterinary (miscellaneous)Scientific OpinionSettore AGR/11 - Entomologia Generale E Applicata570 Life sciences; biologyAnimal Science and ZoologyParasitologymaize 53071103 Animal Science and Zoologybusiness28-day studyFood Science
researchProduct

Assessment of genetically modified sugar beet H7‐1 for renewal of authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐006)

2017

Efsa Panel On Genetically Modified Organisms (gmo)Scientific opinionRequestor: European Commission (DG SANTE)Question number: EFSA-Q-2017-00026; Following the submission of application EFSA-GMO-RX-006 under Regulation (EC) No 1829/2003 fromKWS SAAT SE and Monsanto Company, the Panel on Genetically Modified Organisms of the EuropeanFood Safety Authority (GMO Panel) was asked to deliver a scientific risk assessment on the datasubmitted in the context of the renewal of authorisation application for the herbicide-tolerantgenetically modified sugar beet H7-1. The data received in the context of this renewal applicationcontained a systematic search and evaluation of literature, updated bioinforma…

040301 veterinary sciencesVeterinary (miscellaneous)gmo[SDV]Life Sciences [q-bio]sugarbeetogmPlant Science010501 environmental sciencessugar beet;H7-1;renewal;articles 11 and 23;regulation (EC) No 1829/2003;CP4 EPSPS01 natural sciencesMicrobiology0403 veterinary sciencearticles 11 and 230105 earth and related environmental sciencesrenewalCP4 EPSPSfungiregulation (EC) No 1829/200304 agricultural and veterinary sciencessugar beet10079 Institute of Veterinary Pharmacology and Toxicologybetterave sucrièreH7‐1H7-1Scientific Opinion570 Life sciences; biologyAnimal Science and ZoologyParasitologyregulation (EC) No 1829/2003Food Science
researchProduct

Scientific Opinion on application EFSA‐GMO‐BE‐2013‐118 for authorisation of genetically modified maize MON 87427 × MON 89034 × 1507 × MON 88017 × 591…

2017

Abstract In this opinion, the GMO Panel assessed the five‐event stack maize MON 87427 × MON 89034 ×1507 × MON 88017 × 59122 and its 25 subcombinations, independently of their origin. The GMO Panel has previously assessed the five single events combined to produce this five‐event stack maize and 11 subcombinations of these events and did not identify safety concerns. No new data on the single events or their previously assessed subcombinations, leading to modification of the original conclusions were identified. The combination of the single events and of the newly expressed proteins in the five‐event stack maize did not give rise to issues – based on the molecular, agronomic/phenotypic or c…

040301 veterinary sciencesherbicide toleranceVeterinary (miscellaneous)Context (language use)Plant ScienceGenetically modified crops010501 environmental sciencesBiologymaize01 natural sciencesMicrobiology0403 veterinary scienceEnvironmental safety0105 earth and related environmental sciencesGenetically modified maizebusiness.industryGMOAuthorizationGMO;maize;MON 87427 x MON 89034 x 1507 x MON 88017 x 59122;herbicide tolerance;insect resistance04 agricultural and veterinary sciencesFood safetyZea maysBiotechnologyGenetically modified organismMON87427xMON89034x1507xMON88017x59122Scientific OpinionSettore AGR/11 - Entomologia Generale E ApplicataMON 87427 × MON 89034 × 1507 × MON 88017 × 59122Animal Science and ZoologyParasitologyinsect resistancebusinessFood Science
researchProduct

Chromoendoscopy with indigocarmine improves the detection of adenomatous and nonadenomatous lesions in the colon.

2001

BACKGROUND AND STUDY AIMS Depressed early cancers and flat adenomas have a high potential for malignancy with possible infiltrating growth, despite the small size of the lesion. Japanese investigators have shown that early diagnosis and classification of these lesions is possible with the help of chromoendoscopy. The aim of this study, therefore, was to evaluate the usefulness of chromoendoscopy during routine colonoscopy. PATIENTS AND METHODS During routine colonoscopy, vital staining with indigocarmine solution (0.4 %, 1 - 10 ml) was performed on all visible lesions in 100 consecutive patients without visible inflammatory changes. If findings on macroscopic examination were unremarkable, …

AdenomaAdultMalePathologymedicine.medical_specialtyColonColonoscopyRectumColonic PolypsMalignancyIndigo CarmineSensitivity and SpecificityChromoendoscopyLesionmedicineHumansColoring AgentsAgedmedicine.diagnostic_testStaining and Labelingbusiness.industryGastroenterologySigmoid colonColonoscopyMiddle Agedmedicine.diseasemedicine.anatomical_structureDysplasiaAdenocarcinomaFemalemedicine.symptombusinessColorectal NeoplasmsEndoscopy
researchProduct

Age-dependent shift-to-the-right in the localization of colorectal adenomas.

1987

The age-dependent prevalence and topographical distribution of colorectal adenomas was investigated in 1006 unselected autopsies (554 males and 452 females) in Mainz, FRG. In 200 out of 1006 autopsies (19.8%) a total of 498 adenomas of the large intestine were detected. The percentage of patients with adenomas increased continuously with age. Only 6% of all adenomas were localized in the caecum and 8% in the rectum, whereas all the other adenomas were distributed rather evenly throughout the ascending colon (23%), the transverse colon (25%), the descending colon (15%) and the sigmoid colon (23%). Analyzing the topographical distribution of adenomas for definite age groups (40-59, 60-69, 70-…

AdenomaAdultMalemedicine.medical_specialtyendocrine system diseasesAdenomaAdolescentColorectal cancerRectumGastroenterologyPathology and Forensic MedicineDescending colonRisk FactorsInternal medicineMedicineAscending colonHumansLarge intestineMolecular BiologyAgedAged 80 and overbusiness.industryRectal NeoplasmsTransverse colonAge FactorsSigmoid colonCell BiologyGeneral MedicineMiddle Agedmedicine.diseasedigestive system diseasesstomatognathic diseasesmedicine.anatomical_structureColonic NeoplasmsFemalebusinessVirchows Archiv. A, Pathological anatomy and histopathology
researchProduct

Amplitude, Latency, and Peak Velocity in Accommodation and Disaccommodation Dynamics

2017

The aim of this work was to ascertain whether there are differences in amplitude, latency, and peak velocity of accommodation and disaccommodation responses when different analysis strategies are used to compute them, such as fitting different functions to the responses or for smoothing them prior to computing the parameters. Accommodation and disaccommodation responses from four subjects to pulse changes in demand were recorded by means of aberrometry. Three different strategies were followed to analyze such responses: fitting an exponential function to the experimental data; fitting a Boltzmann sigmoid function to the data; and smoothing the data. Amplitude, latency, and peak velocity of …

AdultArticle Subjectlcsh:MedicineEyeRefraction Ocular050105 experimental psychologyGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciences0302 clinical medicineReaction TimeHumans0501 psychology and cognitive sciencesLatency (engineering)MathematicsGeneral Immunology and MicrobiologyPulse (signal processing)business.industrylcsh:R05 social sciencesMathematical analysisWork (physics)Accommodation OcularGeneral MedicineSigmoid functionExponential functionAmplitude030221 ophthalmology & optometrybusinessAccommodationSmoothingResearch ArticleBioMed Research International
researchProduct

Delayed Coloanal Anastomosis for rectovaginal fistula after colorectal resection for deep endometriosis

2016

The deep infiltrating endometriosis, defined as a subperitoneal infiltration of endometrial implants of ≥ 5 mm involving not only the colorectal tract but also rectovaginal septum, vagina and bladder often requires a challenging surgery. Endometriosis nodes of the rectovaginal septum, if symptomatic, need a resection of the involved colorectal tract with colorectal or coloanal anastomosis. Unfortunately in these cases is not uncommon the possibility of a postoperative rectovaginal fistula (RVF), caused by the weakness of the septum that must be skeletonized to completely remove the endometriosis nodes. Here we present a case of anastomotic leakage with high RVF after colorectal resection an…

AdultColonic DiseaseTime FactorsEndometriosisdeep endometriosisAnastomotic LeakPostoperative HemorrhageColonic DiseasesPostoperative ComplicationsHumansBlood TransfusionEndometriosiSigmoid Diseasesdelayed coloanal anastomosisIleostomyPelvic InfectionAnastomosis SurgicalRectal DiseaseSigmoid Diseaserectovaginal fistulaPleural EffusionRectal Diseasesdeep endometriosis; delayed coloanal anastomosis; rectovaginal fistulaFemalePostoperative ComplicationHuman
researchProduct